Lack of a role for creatine phosphate kinase in sulphur mustard-induced cytotoxicity

Human and Experimental Toxicology

Volumn 26, Issue 11, 2007, Pages 891-897

  Nelson, P ^a   Burczyk, A ^a   Sawyer, T W ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Chemical warfare; Creatine phosphate kinase; Human keratinocytes; Median lethal concentration; Neurons; Sulphur mustard (bis (2 chloroethyl) sulphide)

Indexed keywords

CREATINE KINASE; MUSTARD GAS;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CHEMICAL WARFARE; CHICK EMBRYO; CYTOTOXICITY; EMBRYO; KERATINOCYTE; LC 50; MALE; NERVE CELL CULTURE; NONHUMAN; PLASMA; PRIORITY JOURNAL; SWINE;

ANIMALS; CELLS, CULTURED; CHEMICAL WARFARE AGENTS; CHEMOPREVENTION; CHICK EMBRYO; CREATINE; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; KERATINOCYTES; MUSTARD GAS; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHOCREATINE;

SUIDAE;

EID: 37349066766     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107084043     Document Type: Article

References (27)

1. National Academy Press. Veterans at risk: the health effects of mustard gas and lewisite (Pechura CM and Rall DP eds). Washington, DC, 1993.
2. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. CRC Press, 1991.
3. Smith W, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991; 127: 1207-13.
4. Auerbach C. Chemical mutagenesis. Biol Rev 1949; 24: 355-91.
5. Auerbach C, Robson JM. Chemical production of mutation. Nature 1946; 157: 302.
6. United Nations Security Council (1986). Report of the Mission Dispatched by the Secretary-General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq. March 12, 1986. S/17911, S/17911/Addendum 1 and S/17911/Addendum 2. New York, United Nations.
7. United Nations Security Council (1987). Report of the Mission Dispatched by the Secretary-General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq. May 8, 1987. S/18852 and S/18852/Addendum. New York, United Nations.
8. United Nations Security Council (1988). Report of the Mission Dispatched by the Secretary-General to Investigate Allegations of the Use of Chemical Weapons in the Conflict Between the Islamic Republic of Iran and Iraq. April 25, 1988. S/19823 and S/19823/Addendum 1; July 20, 1988, S/20060 and S/20060/Addendum 1; July 25, 1988, S/20063 and S/20063/Addendum 1; August 19, 1988, S/20134. New York, United Nations.
9. Warthin SW, Weller CV. The medical aspects of mustard gas poisoning. Mosby, 1919.
10. Willems JL. Clinical management of mustard gas casualties. Ann Medicinae Militaris Belgicae 1989; 3(Suppl.): 1-61.
11. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005; 214: 198-209.
12. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 2007; 19: 451-6.
13. Levy MB. (1946). Effects of sulfur and nitrogen mustards on proteins, enzymes, and cells. In: Chemical warfare agents, and related chemical problems, Parts III-IV. Summary Technical Report of Division 9, National Defense Research Committee of the Office of Scientific Research and Development, Washington, DC.
14. Sawyer TW. Modulation of sulfur mustard toxicity by arginine analogues and related nitric oxide synthase inhibitors in vitro. Toxicol Sci 1998; 46: 112-23.
15. Sawyer TW. Toxicity of sulphur mustard in primary neuron culture. Toxicol In Vitro 1999; 13: 249-58.
16. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955; 50: 1096-121.
17. Tukey J. A problem of multiple comparisons. Princeton University Press, 1953.
18. Kramer CY. Extension of multiple range tests to group means with unequal numbers of replications. Biometrica 1956; 12: 309-10.
19. Dixon M, Needham DM. Biochemical research on chemical warfare agents. Nature 1946; 158: 432-38.
20. Papirmeister B, Gross CL, Meier HL, Petrali JP, Johnson JB. Molecular basis of mustard-induced vesication. Fundam Appl Toxicol 1985; 5: S134-49.
21. Smith WJ. Vesicant agents and antivesicant medical countermeasures: clinical toxicology and psychological implications. Mil Psychol 2002; 14: 145-57.
22. Sawyer TW. Synergistic protective effects of selected arginine analogues against sulphur mustard in neuron culture. Toxicol Appl Pharmacol 1999; 155: 169-76.
23. Sawyer TW, Risk D. Effects of selected arginine analogues against sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes. Toxicol Appl Pharmacol 2000; 163: 75-85.
24. Sawyer TW, Hancock JR, D'Agostino PA. L-Thiocitrulline: A potent protective agent against the toxicity of sulphur mustard in vitro. Toxicol Appl Pharmacol 1998; 151: 340-6.
25. Sawyer TW. Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro. Toxicology 1998; 131: 21-32.
26. Sawyer TW, Lundy PM, Weiss MT. Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro. Toxicol Appl Pharmacol 1996; 141: 138-44.
27. Sawyer TW, Vair V, Nelson P, Shei Y, Bjarnason S, Tenn C, McWilliams M, Villanueva M, Burczyk A. pH dependent toxicity of sulphur mustard in vitro. Toxicol Appl Pharmacol 2007; 221: 363-71.